top of page

myLaminin Perspectives


ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now
ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Deanne Bassili
May 74 min read


The Global Clinical Trials Management Challenges
Global clinical trials are growing in scale and complexity as research expands across institutions and jurisdictions. Investigators must manage regulatory compliance, protect sensitive participant data, and maintain strong data governance. Effective clinical trial management systems are essential to support secure collaboration, protocol compliance, and reliable research outcomes.

myLaminin
Mar 164 min read
bottom of page